ASCL1 and central nervous system cancer: The study of Tou et al. showed that the loss of ASCL1 significantly reduces the proliferation of GBMs induced in the brain of a genetically relevant glioma mouse model, resulting in extended survival times, illustrating an important role for ASCL1 in controlling the proliferation of GBM (Du et al., 2015).